共 14 条
- [1] Downregulation of IFN-gamma production in patients with recurrent vaginal candidiasis. Carvalho LP,Bacellar O,Neves N,et al. The Journal of Allergy and Clinical Immunology . 2002
- [2] Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Saporiti AM,Gomez D,Levalle S,et al. Revista Argentina de Microbiologia . 2001
- [3] Increased incidence of vulvovaginal candidiasis caused by candida glabrata in Jordan. Abu EKH. Japanese Journal of Infectious Dieseases . 2001
- [4] Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. Linhares LM,Witkin SS,Miranda SD,et al. Infectious Diseases in Obstetrics and Gynecology . 2001
- [5] Determinants of different candida species infections of the genital tract in women, Sporachrom Study Geoup. Parazzini F,Cintio E,Chiantera V,et al. European Journal of Obstetrics Gynecology and Reproductive Biology . 2000
- [6] Vulvovaginal candidiasis: a comparison of HIV-positive and -negative women. Sobel JD. International Journal of STD and AIDS . 2002
- [7] Oestrogen, glycogen and vaginal candidiasis. Dennerstein G J,Ellis D H. Australian and New Zealand Journal of Obstetrics and Gynaecology . 2001
- [8] Treatment of torulopsis glabuata vaginitis: retrospective review of boric acid therapy. Sobel JD,Chaim W. Clinical Infectious Diseases . 1997
- [9] Growth inhibition of candida by human oral epithelial cells. Steele C,Leigh J,Swoboda R,et al. The Journal of Infectious Diseases . 2000
- [10] Candida albicans allergen immunotherapy in recurrent vaginal candidiasis. Moraes PS,Lima G,Taketomi EA. Journal of Investigational Allergology and Clinical Immunology . 2000